The Food and Drug Administration is advising consumers not to purchase or use Rhino 7S Type F3 7000, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.
Similar Posts
Boothwyn Pharmacy LLC. Kennett Square, PA. 483 issued 06/09/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 06/09/2025
Short Title (70 char) Boothwyn Pharmacy LLC. Kennett Square, PA. 483 issued 06/09/2025
FEI Number 1000076625
Firm Name Boothwyn Pharmacy LLC
Record Type 483
State PA
Establishment Type Producer of SteAngiographic Catheter Recall: Cook Removes Beacon Tip Angiographic Catheters due to Tip Separation
Affected device lots may experience tip separation; field complaints reported that the tip separation can occur both prior to and during patient contact.eCTD Submission Standards for eCTD v4.0 and Regional M1
A listing of the Implementation Guides, Specifications, and Documentation that support the FDA implementation for eCTD v4.0Resources for Biomarker Requestors
Information and resources for requestors about FDA’s Biomarker Qualification ProgramMedWatch: The FDA Safety Information and Adverse Event Reporting Program
MedWatch is made up of voluntary and mandatory reporting on prescription medicines, over-the-counter medicines, non-vaccine biologicals, medical devices, special nutritional products, cosmetics and non-prescription human drug products marketed without an approved application.
